Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
RSS icon

OmniComm Systems Signs Multi-Million Dollar, Five Year Agreement with Top 5 US Medical Research University

FORT LAUDERDALE, Fla., Aug. 02, 2016 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that one of the top 5 medical research universities in the US, selected OmniComm TrialMaster® EDC and related services to conduct a series of clinical studies over a five year period. 

How baby boomers influence the healthcare field

Some 77 million American baby boomers are currently in or near their the golden years, forcing the healthcare industry to accomodate their needs. As this population increasingly visits hospitals and doctors, the entire industry needs to change to handle the influx of patients.

Book-readers live nearly two years longer

Bookworms everywhere can attest how a good read can improve quality of life. But according to a new study published in the journal Social Science and Medicine, reading books could also help improve the length of a person’s life by up to two years, especially in elderly people. 

Biotricity Selects AT&T to Provide Network Connectivity for its Remote Monitoring Solutions

REDWOOD CITY, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has selected AT&T, Inc. as its preferred network partner for providing connectivity to the company’s medical devices.

Wearable temperature monitor provides caregivers with round-the-clock data

Taking a patient's temperature can be a time-consuming duty for both patient and caregiver, but a new app and wearable patch aim to simplify the process.

Calithera Announces Enrollment of First Patient in CB-839 in Combination with Checkpoint Modulator

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced that the first patient has been enrolled in a Phase 1/2 clinical trial assessing the safety and efficacy of CB-839.

Making skin more comfortable by preventing scars

Researchers have developed a method to prevent burn scars, which may help individuals feel more comfortable in their own skin, both mentally and physically.

Cocaine vaccine gets approved for clinical trial on humans

Addicted to cocaine? There might be some hope if you’re longing to kick the addictive drug.

Displaying 2529 - 2536 of 3584

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup